Retirement Planning Co of New England Inc. Boosts Holdings in Humana Inc. (NYSE:HUM)

Retirement Planning Co of New England Inc. grew its position in Humana Inc. (NYSE:HUM) by 4.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 966 shares of the insurance provider’s stock after buying an additional 43 shares during the period. Retirement Planning Co of New England Inc.’s holdings in Humana were worth $245,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Transcend Capital Advisors LLC grew its stake in shares of Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after buying an additional 2,914 shares during the period. FNY Investment Advisers LLC lifted its holdings in shares of Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama lifted its holdings in shares of Humana by 735.9% in the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after acquiring an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Humana by 7.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock worth $244,811,000 after acquiring an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC lifted its holdings in shares of Humana by 190.0% in the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after acquiring an additional 2,660 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM opened at $269.86 on Wednesday. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46. The firm’s fifty day simple moving average is $271.45 and its 200-day simple moving average is $278.29. The firm has a market capitalization of $32.57 billion, a price-to-earnings ratio of 27.12, a PEG ratio of 2.05 and a beta of 0.57. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is 35.58%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on HUM shares. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Nineteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and an average target price of $285.68.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.37% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.